A detailed history of Voya Investment Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 43,016 shares of DVAX stock, worth $575,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,016
Previous 43,904 2.02%
Holding current value
$575,984
Previous $493,000 2.84%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $8,924 - $10,309
-888 Reduced 2.02%
43,016 $479,000
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $15,011 - $17,599
1,399 Added 3.29%
43,904 $493,000
Q1 2024

May 15, 2024

SELL
$11.7 - $14.98 $107,581 - $137,741
-9,195 Reduced 17.79%
42,505 $527,000
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $91 - $104
7 Added 0.01%
51,700 $722,000
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $6,168 - $7,315
488 Added 0.95%
51,693 $763,000
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.17 $59,316 - $79,309
6,022 Added 13.33%
51,205 $661,000
Q1 2023

May 15, 2023

SELL
$9.44 - $11.88 $4,814 - $6,058
-510 Reduced 1.12%
45,183 $443,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $12,362 - $21,712
1,245 Added 2.8%
45,693 $477,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $11,204 - $19,296
1,504 Added 3.5%
44,448 $560,000
Q1 2022

May 16, 2022

BUY
$9.75 - $14.44 $10,647 - $15,768
1,092 Added 2.61%
42,944 $466,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $20.94 $4,122 - $6,554
-313 Reduced 0.74%
41,852 $589,000
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $12,228 - $26,473
-1,335 Reduced 3.07%
42,165 $810,000
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $22,750 - $34,486
-3,138 Reduced 6.73%
43,500 $428,000
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $5,164 - $12,633
1,130 Added 2.48%
46,638 $458,000
Q4 2020

Feb 16, 2021

BUY
$3.73 - $5.6 $36,803 - $55,255
9,867 Added 27.68%
45,508 $203,000
Q3 2020

Nov 16, 2020

BUY
$4.32 - $11.7 $19,876 - $53,831
4,601 Added 14.82%
35,641 $154,000
Q2 2020

Aug 14, 2020

SELL
$2.94 - $9.1 $31,025 - $96,032
-10,553 Reduced 25.37%
31,040 $275,000
Q4 2019

Feb 14, 2020

BUY
$3.46 - $6.93 $31,915 - $63,922
9,224 Added 28.5%
41,593 $238,000
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $8,115 - $14,632
3,017 Added 10.28%
32,369 $116,000
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $13,198 - $28,530
3,616 Added 14.05%
29,352 $117,000
Q1 2019

May 15, 2019

SELL
$7.08 - $12.09 $10,563 - $18,038
-1,492 Reduced 5.48%
25,736 $188,000
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $18,958 - $30,929
2,329 Added 9.35%
27,228 $249,000
Q2 2018

Aug 14, 2018

SELL
$15.15 - $20.75 $45,268 - $62,001
-2,988 Reduced 10.71%
24,899 $380,000
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $423,882 - $599,570
27,887
27,887 $600,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.69B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.